BPK3079 Citations (4)

Originally described in: Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
Kleinstiver BP, Tsai SQ, Prew MS, Nguyen NT, Welch MM, Lopez JM, McCaw ZR, Aryee MJ, Joung JK Nat Biotechnol. 2016 Jun 27. doi: 10.1038/nbt.3620. PubMed Journal

---

Articles Citing BPK3079

Articles
Generation of the Adenovirus Vector-Mediated CRISPR/Cpf1 System and the Application for Primary Human Hepatocytes Prepared from Humanized Mice with Chimeric Liver. Tsukamoto T, Sakai E, Iizuka S, Taracena-Gandara M, Sakurai F, Mizuguchi H. Biol Pharm Bull. 2018;41(7):1089-1095. doi: 10.1248/bpb.b18-00222. PubMed
Increasing the specificity of CRISPR systems with engineered RNA secondary structures. Kocak DD, Josephs EA, Bhandarkar V, Adkar SS, Kwon JB, Gersbach CA. Nat Biotechnol. 2019 Jun;37(6):657-666. doi: 10.1038/s41587-019-0095-1. Epub 2019 Apr 15. PubMed
Controlling Gene Expression in Mammalian Cells Using Multiplexed Conditional Guide RNAs for Cas12a*. Oesinghaus L, Simmel FC. Angew Chem Int Ed Engl. 2021 Oct 25;60(44):23894-23902. doi: 10.1002/anie.202107258. Epub 2021 Sep 29. PubMed
A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation. Wang X, Dong K, Kong D, Zhou Y, Yin J, Cai F, Wang M, Ye H. Sci Adv. 2021 Dec 10;7(50):eabh2358. doi: 10.1126/sciadv.abh2358. Epub 2021 Dec 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.